UPDATE: Scrip's World of Inflammation – what's new?
This article was originally published in Scrip
A lot has happened in the field of inflammatory diseases since Scrip published its popular World of Inflammation matrix of the key products and companies in December. So much so, that we have had to update it with all the latest movements to help you keep tabs on what's going on in this important therapy area.
You may also be interested in...
The leading PARP inhibitor gets a new tumor type added to its label after a narrow ODAC vote in favor less than a fortnight ago.
Andrew McConaghie and Alex Shimmings are joined by John Hawkins, biographer of biotech pioneer Henri Termeer, and Idea Pharma's Mike Rea to pick out their personal book highlights of 2019.
Concerns that written interventions might delay the expected EU approval of the novel ketamine-based antidepressant have come to naught.